Reproductive medicine and Turner syndrome: ethical issues

Area of Science:

• Medical Ethics
• Reproductive Medicine
• Genetics

Background:

• Turner syndrome (TS) presents unique challenges for affected women and their families.
• Social attitudes significantly influence the experiences and medical decisions related to TS.
• Existing medical interventions for TS raise complex ethical questions.

Purpose of the Study:

• To critically analyze the ethical issues associated with medical interventions for Turner syndrome.
• To explore the perspectives of women with TS and prospective parents regarding these interventions.
• To examine the ethical implications of specific treatments like growth hormone therapy, third-party oocytes, ovarian tissue cryopreservation, and fetal termination.

Main Methods:

• Ethical analysis of medical interventions for Turner syndrome.
• Review of literature on patient and parental experiences with TS.
• Discussion of four key ethical issues: growth hormone use, third-party oocytes, ovarian tissue cryopreservation, and fetal termination.

Main Results:

• Medical interventions for TS, while aiming to alleviate difficulties, carry significant risks and consent concerns.
• Social factors, including stigma and assumptions by health professionals, complicate ethical decision-making.
• Decisions regarding interventions must consider both medical risks and the social context of TS.

Conclusions:

• Interventions for Turner syndrome require careful consideration of ethical principles, including risk and consent.
• Addressing social attitudes is crucial for improving the well-being of individuals with TS.
• Medical responses should acknowledge and integrate the social dimensions of Turner syndrome.